24.75
                                            Schlusskurs vom Vortag:
              $26.73
            Offen:
              $26.46
            24-Stunden-Volumen:
                1.34M
            Relative Volume:
              1.12
            Marktkapitalisierung:
                $1.64B
            Einnahmen:
              $5.79M
            Nettoeinkommen (Verlust:
              $-199.61M
            KGV:
              -8.2226
            EPS:
                -3.01
            Netto-Cashflow:
                $-188.48M
            1W Leistung:
              -9.57%
            1M Leistung:
              -6.29%
            6M Leistung:
                +19.80%
            1J Leistung:
              -3.62%
            Celldex Therapeutics Inc Stock (CLDX) Company Profile
Firmenname
                  
                      Celldex Therapeutics Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      908-200-7500
                    
                Adresse
                  
                      53 FRONTAGE ROAD, HAMPTON
                    
                Vergleichen Sie CLDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                CLDX
                            
                             
                        Celldex Therapeutics Inc 
                           | 
                    24.75 | 1.78B | 5.79M | -199.61M | -188.48M | -3.01 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Celldex Therapeutics Inc Stock (CLDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-10-21 | Eingeleitet | Mizuho | Outperform | 
| 2025-10-13 | Eingeleitet | Barclays | Underweight | 
| 2025-04-28 | Eingeleitet | Canaccord Genuity | Buy | 
| 2025-03-20 | Eingeleitet | Morgan Stanley | Overweight | 
| 2025-02-13 | Eingeleitet | UBS | Buy | 
| 2024-10-07 | Eingeleitet | Citigroup | Buy | 
| 2024-09-30 | Eingeleitet | Goldman | Neutral | 
| 2024-09-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform | 
| 2024-06-18 | Eingeleitet | Stifel | Buy | 
| 2024-06-11 | Eingeleitet | Wolfe Research | Outperform | 
| 2023-12-20 | Eingeleitet | TD Cowen | Outperform | 
| 2023-11-10 | Hochstufung | Wells Fargo | Underweight → Equal Weight | 
| 2023-08-22 | Eingeleitet | Wells Fargo | Underweight | 
| 2021-09-17 | Eingeleitet | Jefferies | Buy | 
| 2021-09-10 | Eingeleitet | SVB Leerink | Outperform | 
| 2021-07-22 | Eingeleitet | Guggenheim | Buy | 
| 2020-02-21 | Eingeleitet | Cantor Fitzgerald | Overweight | 
| 2017-08-01 | Fortgesetzt | H.C. Wainwright | Buy | 
| 2016-11-07 | Eingeleitet | Aegis Capital | Buy | 
| 2016-03-08 | Herabstufung | Jefferies | Buy → Hold | 
| 2016-03-07 | Herabstufung | Guggenheim | Buy → Neutral | 
| 2016-03-07 | Herabstufung | Leerink Partners | Outperform → Mkt Perform | 
| 2016-03-07 | Herabstufung | Wedbush | Outperform → Neutral | 
| 2016-03-01 | Eingeleitet | H.C. Wainwright | Buy | 
| 2015-08-11 | Bestätigt | Brean Capital | Buy | 
| 2015-08-11 | Bestätigt | Oppenheimer | Outperform | 
| 2015-08-11 | Bestätigt | ROTH Capital | Buy | 
| 2015-06-02 | Bestätigt | WBB Securities | Strong Buy | 
| 2014-11-17 | Bestätigt | ROTH Capital | Buy | 
| 2014-03-04 | Bestätigt | Oppenheimer | Outperform | 
| 2013-07-08 | Bestätigt | Cantor Fitzgerald | Buy | 
| 2013-03-08 | Bestätigt | Cantor Fitzgerald | Buy | 
| 2013-02-26 | Bestätigt | Oppenheimer | Outperform | 
| 2013-01-10 | Bestätigt | Cantor Fitzgerald | Buy | 
| 2012-10-02 | Bestätigt | Oppenheimer | Outperform | 
| 2012-09-14 | Bestätigt | Cantor Fitzgerald | Buy | 
                    Alle ansehen
                    
                  
                Celldex Therapeutics Inc Aktie (CLDX) Neueste Nachrichten
Why Celldex Therapeutics Inc. stock could be next big winner2025 Dividend Review & Smart Allocation Stock Tips - newser.com
Y Intercept Hong Kong Ltd Takes $1.19 Million Position in Celldex Therapeutics, Inc. $CLDX - MarketBeat
How to use a screener to detect Celldex Therapeutics Inc. breakouts2025 Technical Patterns & Growth Focused Stock Pick Reports - newser.com
Can Celldex Therapeutics Inc. stock reach $100 price target2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com
Celldex Therapeutics Inc. stock momentum explained2025 Key Lessons & Capital Efficiency Focused Strategies - newser.com
Will Celldex Therapeutics Inc. (TCE2) stock outperform energy sector in 2025Volume Spike & Weekly Watchlist for Consistent Profits - newser.com
Identifying reversal signals in Celldex Therapeutics Inc.July 2025 Momentum & Free Expert Approved Momentum Trade Ideas - newser.com
Visualizing Celldex Therapeutics Inc. stock with heatmapsMarket Activity Recap & Entry Point Confirmation Alerts - newser.com
Why Celldex Therapeutics Inc. stock could benefit from AI revolution2025 Momentum Check & Weekly Return Optimization Alerts - newser.com
Is Celldex Therapeutics Inc. stock reversal real or fakeCPI Data & Stock Portfolio Risk Management - newser.com
Real time social sentiment graph for Celldex Therapeutics Inc.July 2025 Trends & Community Consensus Picks - newser.com
Why analysts remain bullish on Celldex Therapeutics Inc. stockWeekly Stock Recap & Consistent Growth Stock Picks - newser.com
Using data filters to optimize entry into Celldex Therapeutics Inc.July 2025 Market Mood & Advanced Technical Analysis Signals - newser.com
Published on: 2025-11-03 04:54:12 - newser.com
Is it too late to sell Celldex Therapeutics Inc.July 2025 Analyst Calls & Safe Entry Point Alerts - newser.com
What MACD and RSI say about Celldex Therapeutics Inc.Earnings Beat & High Conviction Buy Zone Picks - newser.com
Will Celldex Therapeutics Inc. stock benefit from upcoming earnings reportsForecast Cut & Expert Curated Trade Ideas - newser.com
What momentum shifts mean for Celldex Therapeutics Inc.Exit Point & AI Enhanced Trading Alerts - newser.com
Published on: 2025-11-03 00:38:35 - newser.com
Signal strength of Celldex Therapeutics Inc. stock in tech scannersJuly 2025 Selloffs & Safe Entry Point Identification - newser.com
Reversal indicators forming on Celldex Therapeutics Inc. stockMarket Trend Report & Capital Protection Trade Alerts - newser.com
Published on: 2025-11-02 12:29:41 - newser.com
What’s next for Celldex Therapeutics Inc. stock priceQuarterly Risk Review & Free Weekly Watchlist of Top Performers - newser.com
Positive Early CDX-622 Data Might Change The Case For Investing In Celldex Therapeutics (CLDX) - Sahm
Is Celldex Therapeutics Inc. stock a bargain at current levelsWeekly Trade Review & Free Technical Confirmation Trade Alerts - newser.com
Chart overlay techniques for tracking Celldex Therapeutics Inc.Quarterly Trade Report & Precise Buy Zone Tips - newser.com
Real time alert setup for Celldex Therapeutics Inc. performanceJuly 2025 Opening Moves & Intraday High Probability Alerts - newser.com
How Celldex Therapeutics Inc. (TCE2) stock trades in high volatility2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - newser.com
Finanzdaten der Celldex Therapeutics Inc-Aktie (CLDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):